Japanese drug makers report no major damage from quake; Lupin aims to launch more drugs in Japan;

@FiercePharma: McNeil Consumer Healthcare reaches consent decree with FDA. Report | Follow @FiercePharma 

> Indian drugmaker Lupin aims to begin sales of 10 new products in Japan through its unit Kyowa Pharmaceutical over the next year. Story

> Dave Urdal, Dendron's chief scientific officer, says he will retire at the end of the year. Story

> A story analyzes the FDA's controversial decision to grant fast-track approval to KV Pharmaceutical for its prenatal drug, Makena. Story

> Japanese drugmakers have not reported major damage from the mighty earthquake and tsunami that hit Japan on Friday. Story

Biotech News

@FierceBiotech: Roche, Novartis make MIT innovators list. Item | Follow @FierceBiotech

> HIV drugs' blockbuster success is hampering new development efforts. News

> Omthera rounds up $34M in Series B, adds David Mott to board. Story 

> U.S. HIV drug developer Koronis eyes London listing. Article 

> The view from Bio-Europe 2011. Item 

Biotech IT News

> Researchers get a jump on NCI trials group revamp. Item

> Biogen Idec arthritis model gets personal. Report

> PPDI develops portal to hold volunteers. Item 

> Integration, joint trials will speed approvals. Article 

> Cold call symbolizes CIO scourge: tech marketing. Story

> Biopsies trump imaging in cancer-spread trial. News

Medical Device News

> FDA says no to Medtronic's Amplify. News

> Edwards Lifesciences completes $43M Embrella buy. Story

> Breathe Technologies looks to move HQ to OC. Item

> Boston Sci, St. Jude settle breach-of-contract dispute. Article

> FDA OKs Covidien's LEU-based isotope production‎. Report

> Medtronic opens manufacturing facility in Singapore. Item

And Finally...  The pharmacy at UCSF Medical Center hands out something like 10,000 doses of medication per day. That's a lot of pills. But UCSF has invested in a team of robotic pharmacy workers that can handle prescriptions all the way from electronic orders from doctors and nurses to dispensing individual pills, arranged on a handy plastic ring in order of when they should be taken. News

Suggested Articles

Seattle Genetics and Astellas’ newcomer Padcev now has what every cancer drugmaker is looking for: Randomized trial data showing it can extend lives.

A patent decision in Delaware clears the way for multiple generic companies to launch their Tecfidera copycats—and target its $3.3B in U.S. sales.

Sanofi and GlaxoSmithKline signed a deal with the EU to supply up to 300 million doses of their recombinant protein-based COVID-19 vaccine.